EPI-003

· Epigenic Therapeutics, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EPI-003, covering 2024-10-28 to 2024-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients [Phase 1]